iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

LIC boosts its stake in Dr Reddy's Laboratories from 5.65% to 7.7%

4 Oct 2022 , 08:45 AM

Life Insurance Corporation of India (LIC) expanded its interest in the pharmaceutical company to 7.7% on Monday, according to Dr Reddy’s Laboratories Ltd (DRL), which claimed it did so by purchasing 33.86 lakh shares in the open market over time.

According to a regulatory filing from DRL, LIC formerly owned around 5.65% of the firm.

LIC acquired 33,86,486 shares of DRL from the open market between June 15, 2022, and September 30, 2022, totaling a 2.034 percent ownership, it was noted. The company’s ownership by LIC now amounts to 7.7%.


For feedback and suggestions, write to us at editorial@iifl.com

Related Tags

  • BSE
  • business
  • Companies
  • Dr Reddys Laboratories Ltd
  • DRL
  • LIC
  • markets
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.